{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T16:15:09Z","timestamp":1783786509248,"version":"3.55.0"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Dermatol Surg","DS"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND<\/jats:title>\n                    <jats:p>Melasma is an acquired hypermelanosis. Chemical peels have been found efficacious in melasma. However, limited studies have compared the efficacy of various peels in melasma and used dermoscopy to evaluate improvement.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>To compare the efficacy of 35% glycolic acid peel and 4% retinol peel in melasma using clinical, dermoscopic, and quality of life assessments.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MATERIALS AND METHODS<\/jats:title>\n                    <jats:p>\n                      A randomized controlled study included 60 adults (18\u201360 years) with clinically diagnosed melasma. Participants were randomized into Group A (glycolic acid) and Group B (retinol), receiving 6 sessions of peels at two-week intervals. Pretreatment and post-treatment assessments included modified Melasma Area Severity Index (mMASI), dermoscopic scoring, and Hindi Melasma Quality of Life Index (HI-MELASQOL). Statistical analysis used\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      -values &lt;0.05 for significance.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>\n                      Both groups showed significant improvements in mMASI, dermoscopic features, and HI-MELASQOL (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt; .001) with no significant difference between groups. Mild, self-limiting adverse effects were more common in the retinol group (13.3%) than the glycolic acid (3.3%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>Both 35% glycolic acid and 4% retinol peels are effective in treating melasma, with significant improvements in pigmentation, dermoscopic features, and quality of life. No significant difference was observed between the 2 treatments. Dermoscopy is useful to assess response.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/dss.0000000000004858","type":"journal-article","created":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T14:00:49Z","timestamp":1758290449000},"page":"232-236","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Comparative Efficacy of 35 % Glycolic Acid Peel versus 4 % Retinol Peel in Melasma"],"prefix":"10.1097","volume":"52","author":[{"given":"Taku","family":"Rini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashmi","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bharati","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vibhu","family":"Mendiratta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taru","family":"Garg","sequence":"additional","affiliation":[{"name":"All authors are affiliated with the Department of Dermatology, Lady Hardinge Medical College, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,9,19]]},"reference":[{"key":"R1-20260227","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.jaad.2010.12.046","article-title":"Melasma: a comprehensive update: part I","volume":"65","author":"Sheth","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"R2-20260227","doi-asserted-by":"crossref","first-page":"70","DOI":"10.4103\/2349-5847.147044","article-title":"Recent advances in melasma","volume":"1","author":"Chatterjee","year":"2014","journal-title":"Pigment Int"},{"key":"R4-20260227","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1001\/archderm.138.12.1578","article-title":"Efficacy of glycolic acid peels in the treatment of melasma the treatment of melasma","volume":"138","author":"Hurley","year":"2002","journal-title":"Arch Dermatol"},{"key":"R5-20260227","first-page":"932","article-title":"A stabilized 0.1% retinol facial moisturizer improves the appearance of photodamaged skin in an eight-week, double-blind, vehicle-controlled study","volume":"8","author":"Samaras","year":"2009","journal-title":"J Drugs Dermatol"},{"key":"R6-20260227","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1001\/archderm.143.5.606","article-title":"Improvement of naturally aged skin with vitamin A (retinol) A (retinol)","volume":"143","author":"Kafi","year":"2007","journal-title":"Arch Dermatol"},{"key":"R7-20260227","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/1523-1747.ep12323445","article-title":"Application of retinol to human skin in vivo induces epidermal hyperplasia and cellular retinoid binding proteins characteristic of retinoic acid but without measurable retinoic acid levels or irritation epidermal hyperplasia and cellular retinoid binding proteins characteristic of retinoic acid but without measurable retinoic acid levels or irritation","volume":"105","author":"Kang","year":"1995","journal-title":"J Invest Dermatol"},{"key":"R8-20260227","first-page":"41","article-title":"A novel, volumizing cosmetic formulation significantly improves the appearance of target glabellar lines, nasolabial folds, and Crow's feet in a double-blind, vehicle-controlled clinical trial formulation significantly improves the appearance of target glabellar lines, nasolabial folds, and crow's feet in a double-blind, vehicle-controlled clinical trial","volume":"13","author":"Farris","year":"2014","journal-title":"J Drugs Dermatol"},{"key":"R9-20260227","first-page":"1645","article-title":"A novel mode of action to stimulate collagen production in aged skin cells","volume":"22","author":"Khusial","year":"2012","journal-title":"J Glycobiol"},{"key":"R10-20260227","first-page":"47","article-title":"A firming neck cream containing N-Acetyl glucosamine significantly improves signs of aging on the challenging neck and d\u00e9colletage containing N-acetyl glucosamine significantly improves signs of aging on the challenging neck and d\u00e9colletage","volume":"15","author":"Schlessinger","year":"2016","journal-title":"J Drugs Dermatol"},{"key":"R11-20260227","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.det.2018.05.014","article-title":"Dermoscopy of pigmentary disorders in brown skin","volume":"36","author":"Chatterjee","year":"2018","journal-title":"Dermatol Clin Clin"},{"key":"R12-20260227","doi-asserted-by":"crossref","first-page":"519","DOI":"10.4103\/0019-5154.164415","article-title":"Clinico-epidemiological study and quality of life assessment in melasma life assessment in melasma","volume":"60","author":"Yalamanchili","year":"2015","journal-title":"Indian J Dermatol"},{"key":"R13-20260227","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1007\/s13555-020-00455-y","article-title":"Dermoscopy in monitoring and predicting therapeutic response in general dermatology (Non-Tumoral dermatoses): an up-to-date overview dermatology (non-tumoral dermatoses): An upato-date overview","volume":"10","author":"Errichetti","year":"2020","journal-title":"Dermatol Ther (Heidelb)"},{"key":"R14-20260227","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1080\/09546634.2019.1708847","article-title":"A comparative study between oral tranexamic acid versus oral tranexamic acid and Q-switched Nd-YAG laser in melasma treatment: a clinical and dermoscopic evaluation tranexamic acid versus oral tranexamic acid and Q-switched Nd-YAG laser in melasma treatment: a clinical and dermoscopic evaluation","volume":"32","author":"Agamia","year":"2021","journal-title":"J Dermatolog Treat"},{"key":"R15-20260227","first-page":"e13629","article-title":"Dermoscopy as a useful tool for evaluating melasma and assessing the response to 1064-nm Q-switched Nd:YAG laser","volume":"33","author":"Hay","year":"2020","journal-title":"Dermatol Ther"},{"key":"R16-20260227","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4103\/0378-6323.168937","article-title":"Development and validation of a Hindi language health-related quality of life questionnaire for melasma in Indian patients","volume":"82","author":"Sarkar","year":"2016","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R17-20260227","first-page":"756","article-title":"Tretinoin peels versus glycolic acid peels in the treatment of melasma in dark-skinned patients treatment of melasma in dark-skinned patients","volume":"30","author":"Khunger","year":"2004","journal-title":"Dermatol Surg"},{"key":"R20-20260227","doi-asserted-by":"crossref","first-page":"e15107","DOI":"10.1111\/dth.15107","article-title":"Topical 5% tranexamic acid with 30% glycolic acid peel: an useful combination for accelerating the improvement in melasma peel: A useaul combination for accelerating the improvement in melasma","volume":"34","author":"Sahu","year":"2021","journal-title":"Dermatol Ther Ther"},{"key":"R21-20260227","first-page":"17","article-title":"Double-blind randomized study of 5% and 10% retinoic acid peels in the treatment of melasma: clinical evaluation and impact on the quality of life","volume":"3","author":"Magalh\u00e3es","year":"2011","journal-title":"Surgcosmet Dermatol"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000004858","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T14:02:38Z","timestamp":1772200958000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000004858"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,19]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/dss.0000000000004858","relation":{},"ISSN":["1076-0512","1524-4725"],"issn-type":[{"value":"1076-0512","type":"print"},{"value":"1524-4725","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,19]]}}}